Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Akari Therapeutics PLC (AKTX) had Weighted-Average Shares Outstanding (Diluted) of 1.79M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-4.81M |
|
-- |
|
-- |
|
$4.60M |
|
$-4.60M |
|
$-0.20M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-4.81M |
|
$-4.60M |
|
$-4.60M |
|
1.79M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.79M |
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$8.32M |
|
-- |
|
$30.30M |
|
$38.62M |
|
$13.94M |
|
-- |
|
$6.09M |
|
$20.03M |
|
$18.59M |
|
$-11.71M |
|
$18.59M |
|
1.75M |
|
| Cash Flow Statement Financials | |
$-5.60M |
|
-- |
|
$8.09M |
|
$5.26M |
|
$7.75M |
|
$2.49M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.60 |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.85% |
|
41.07% |
|
-12.45% |
|
-25.85% |
|
$10.62 |
|
$-3.12 |
|
$-3.12 |
|